Skip to content

Generate Biomedicines, Inc. GENB Finance Lease Liabilities

Finance Lease Liabilities at other companies

MYR Group logo
MYR GroupMYRG
$998K-42.8%
SSR Mining logo
SSR MiningSSRM
$91K-99.9%
GHC
Graham HoldingsGHC
$7.06M+39.9%
PBF Energy logo
PBF EnergyPBF
$22.6M-30.7%
CNX Resources logo
CNX ResourcesCNX
$23.72M+16.8%
ADT logo
ADTADT
$20.56M-46.8%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's finance lease liabilities?
Generate Biomedicines, Inc. (GENB) reported finance lease liabilities of $2.22M in Q1 2026.
What does finance lease liabilities mean?
Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.